NCT02057133 2026-01-26A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has SpreadEli Lilly and CompanyPhase 1 Active not recruiting198 enrolled
NCT05252988 2025-04-01DIANERSpanish Breast Cancer Research GroupPhase 2 Active not recruiting177 enrolled